About MeI’m a surgical oncologist with a focus on treating patients with a variety of gastrointestinal cancers. My areas of expertise include appendiceal cancer, metastatic colorectal cancer, gastric cancer, and peritoneal surface malignancies (appendix, colon, gastric, peritoneal mesothelioma). I’m driven by a desire to pursue effective and less invasive surgical treatments when appropriate, but sometimes surgical therapies require an aggressive, more invasive strategy to achieve the goals of disease control and potential cure. I was rated in the top 10 percent of physicians in the nation for patient satisfaction in 2016 and 2017.
I serve as clerkship director (Surgery Unit Director) for The Ohio State University College of Medicine, and am an assistant professor of surgery. Like all of my colleagues here, I’m inspired every day by The James’ role as a pioneer in discoveries that get us closer to a cancer-free world.
I’ve presented more than a dozen medical abstracts nationwide, and have contributed to 15 published manuscripts. Currently I serve on the editorial board of the World Journal of Surgical Oncology.
Additionally, I’m a fellow with the American College of Surgeons (FACS), and a member of the American Hepato-Pancreatico-Biliary Association, the Society of American Gastrointestinal and Endoscopic Surgeons and the Society of Surgical Oncology.
- Rated in the top 10 percent of physicians in the nation for patient satisfaction, 2016, 2017
- Named to the Castle Connolly list of America’s “Top Doctors” for 2017
Specialties and conditions I treat
- Surgical Oncology
- Gastrointestinal Cancers
- Pancreatic Cancers
- Small Intestine Cancer
- Minimally Invasive Surgical Procedures
Locations where I practice
Education and training
Jefferson Medical College
Cleveland Clinic Hospital
7/1/2004 - 6/30/2008
More about my work
Ohio State University Wexner Medical Center
7/7/2008 - 6/30/2010
American Board of Surgery
American Board of Surgery
Consulting and Related Relationships
At The Ohio State University Wexner Medical Center, we support a faculty member’s research and consulting in collaboration with medical device, research and/or drug companies because a faculty member’s expertise can guide important advancements in the practice of medicine and improve patient care. In order to provide effective management of these relationships, the University requires annual disclosures from all faculty members with external interests related to their University responsibilities.
As of 03/28/2017, Dr. Abdel-Misih has reported no financial relationships with medical device, research and/or drug companies.